This compound is primarily utilized in pharmaceutical research and development, particularly in the synthesis of active pharmaceutical ingredients (APIs). It serves as a key intermediate in the production of certain drugs, especially those targeting neurological and psychiatric disorders. Its structural properties make it valuable for creating compounds that interact with specific receptors in the brain, potentially aiding in the treatment of conditions like depression, anxiety, or schizophrenia. Additionally, it may be used in preclinical studies to explore its pharmacokinetics and pharmacodynamics, helping researchers understand its efficacy and safety profile. Its trihydrochloride form enhances solubility, making it more suitable for formulation in various drug delivery systems.